| 1 | (4) Policy Briefing: A new agenda for CMS, the Biden White House, and a Democratic Congress 2021-02-07 |
Play |
| 2 | (3) The Part B IPI Model 2018-12-14 |
Play |
| 3 | (2) IDN and Pharma Collaborations 2018-12-07 |
Play |
| 4 | (1): Outcomes Based Agreements: Deal or No Deal 2018-08-01 |
Play |
The Certara Market Access Channel
Welcome to the Market Access Podcast, your expert briefing on the latest in Market Access and Health Economics in the Bio-Pharmaceutical Industries.
